A detailed history of Mariner, LLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Mariner, LLC holds 12,203 shares of OPTN stock, worth $6,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,203
Previous 12,203 -0.0%
Holding current value
$6,223
Previous $12,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.82 - $1.44 $388 - $682
-474 Reduced 3.74%
12,203 $12,000
Q1 2024

May 15, 2024

SELL
$1.17 - $1.94 $25,147 - $41,698
-21,494 Reduced 62.9%
12,677 $18,000
Q4 2023

Feb 14, 2024

BUY
$1.02 - $1.47 $20,764 - $29,924
20,357 Added 147.36%
34,171 $44,000
Q3 2023

Nov 13, 2023

BUY
$0.93 - $1.38 $677 - $1,006
729 Added 5.57%
13,814 $16,000
Q2 2023

Aug 11, 2023

BUY
$1.11 - $2.05 $260 - $481
235 Added 1.83%
13,085 $16,000
Q1 2023

May 12, 2023

BUY
$1.63 - $2.02 $20,945 - $25,957
12,850 New
12,850 $25,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $42.5M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.